UPC logo

Universe Pharmaceuticals Inc.

UPC
Healthcare|Drug Manufacturers - Specialty & Generic|CN
$1.39
-0.01 (-0.71%)
DCF Value
$7243.81
Tangible Book / Share
$98.23
Cash / Share
$51.57

About

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.

Stock Price

-64.9%(1Y)
1M
-66.7%
3M
-75.0%
6M
-50.4%
YTD
-63.5%
1Y
-62.4%
3Y
-99.8%
5Y
-100.0%

Pipeline Summary

2 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
Unknown: 1Recruiting: 1

Active Trials (1)

Autism - Children's Improvisational Music Therapy Evaluation
NCT06016621Autism
N/ARecruiting
Enrollment: 240 participants

Key Facts

Market Cap$878.1K
Employees216
CEOGang Lai
IPO DateMar 23, 2021
Beta1.85
52-Week Range$1.33 – $17.96
Avg Volume1,535,471
ExchangeNASDAQ

Ownership

Float77.1%
Shares Outstanding0.6M

Recent Insider Trades

Lai GangAWARD
May 7, 202671,890 shares
Lai GangAWARD
May 7, 202612,610 shares
Zheng DingOTHER
Mar 18, 20260 shares
Lai GangOTHER
Mar 18, 20260 shares
Liu BaochangOTHER
Mar 18, 20260 shares

Peers

BCTXZBriaCell Therapeutics Corp. Warrant
$212.5K
BJDXBluejay Diagnostics, Inc.
$2.6M
ELABPMGC Holdings Inc.
$1.3M
MLECMoolec Science S.A.
$617.2K
NCELNewcelX Ltd.
$1.2M
NKGNNKGen Biotech, Inc.
$1.4M
PRFXPRF Technologies Ltd.
$70.1K
SHPHShuttle Pharmaceuticals Holdings, Inc.
$26.6M
Data last updated: Nov 9, 2026, 04:38 AM